Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16969706

Download in:

View as

General Info

PMID
16969706